Fermenta Biotech Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,59,537 shares, with a market capitalization of ₹29430987. Its Average Traded Price (ATP) is ₹507.58, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹520.65.
Fermenta Biotech has an upper circuit limit of ₹582.95 and a lower circuit limit of ₹388.65. The total value traded stands at ₹8.10 CR, and the delivery percentage for the day is 39.68%.
The stock is currently traded with a market lot size of 1. Fermenta Biotech also offers a dividend yield of 0.77%.
Fermenta Biotech share price chart
Fermenta Biotech Share Key Metrics
Volume
1.60 L
Market Cap
1532.32 CR
LTQ@LTP
2@520.65
ATP
507.58
Var Margin
25.27 %
Circuit Range
388.65-582.95
Delivery %
39.68 %
Value
8.10 CR
ASM/GSM
No
Market Lot
1
Fermenta Biotech Resistance and Support
Pivot 491.17
Resistance
First Resistance
504.54
Second Resistance
523.27
Third Resistance
536.64
Support
First Support
472.44
Second Support
459.07
Third Support
440.34
Fermenta Biotech Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Fermenta Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-11 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-05 | 2026-08-05 | View More |
Fermenta Biotech News
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fermenta Biotech will hold a physical one-to-one investor meeting on August 21, 2026, in Mumbai. The company confirmed that no unpublished price sensitive information is intended to be discussed.
Aug 17 2026 16:48:46
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Credit Rating
Fermenta Biotech's credit ratings for bank facilities have been upgraded by CARE Ratings. Long-term facilities now rated CARE BBB+; Stable (from CARE BBB; Stable) and short-term facilities CARE A2 (from CARE A3+).
Aug 17 2026 16:40:57
Fermenta Biotech Ltd - 506414 - Presentation For Shareholders At 74Th Annual General Meeting ('AGM')
Fermenta Biotech's AGM presentation detailed robust FY26 performance with revenue of Rs.548 cr and PAT of Rs.70 cr. Key approvals include a Rs.110 cr capex for new Dahej capacity and an Indian patent for plant-source Vitamin D3, enhancing market access.
Aug 11 2026 14:37:09
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fermenta Biotech reported Q1 FY27 consolidated revenue of INR 126.2 crore, a 13% YoY decrease, and net profit of INR 9.5 crore, down 56% YoY. The decline was attributed to an exceptionally strong base quarter and non-recurring items.
Aug 11 2026 13:37:27
Fermenta Biotech Ltd - 506414 - Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results - June 30, 2026.
Fermenta Biotech's Board approved Q1 FY27 standalone and cons. financial results on August 11, 2026. Consolidated revenue declined 10.59% YoY to ₹121.82 cr, while net profit dropped 55.88% YoY to ₹9.53 cr, reflecting a challenging quarter.
Aug 11 2026 13:18:56
Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026.
Fermenta Biotech's Board of Directors will meet on August 11, 2026, to consider and approve the company's Q1 FY27 financial results. This meeting will finalize the unaudited standalone and consolidated figures for the quarter ended June 30, 2026.
Aug 04 2026 17:52:22
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fermenta Biotech Limited's 2.94 crore equity shares (face value ₹5 each) have been listed on the National Stock Exchange (NSE) from August 4, 2026. This dual listing with BSE aims to increase accessibility, market visibility, and price discovery for its shares.
Aug 04 2026 17:33:34
Fermenta Biotech Management
| Name | Position |
|---|---|
| Pradeep Chandan | Non Executive Independent Director |
| Rajeshwari Datla | Non Executive Director |
Fermenta Biotech Similar Stocks
Syncom Formulations (India) Ltd.
21.39
1.32 (6.58%)
Krsnaa Diagnostics Ltd.
553.10
-6.85 (1.22%)
Suraksha Diagnostic Ltd.
340.35
-0.45 (0.13%)
Shalby Ltd.
151.33
-2.32 (1.51%)
NGL Fine-Chem Ltd.
2688.70
31.10 (1.17%)
Amrutanjan Health Care Ltd.
500.25
1.90 (0.38%)
Jagsonpal Pharmaceuticals Ltd.
237.03
-2.60 (1.09%)
Q-Line Biotech Ltd.
619.55
32.50 (5.54%)
KMC Speciality Hospitals (India) Ltd.
133.19
-0.13 (0.10%)
GPT Healthcare Ltd.
150.83
-0.80 (0.53%)
Fermenta Biotech FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in FERMENTA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC